Answers are grounded in this paper and cite their sources.
Cohort study demonstrates serum peripherin as a biomarker for PNS damage, implying early diagnosis potential in patients with hereditary ATTR amyloidosis.
This study demonstrates that serum peripherin represents a promising biomarker for early detection of PNS damage in ATTRv, with elevated levels detectable even in presymptomatic stages.
No takes yet. Share an insight, caveat, or question.
Plantone et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: